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INTRODUCTION
C. albicans is the major fungal 
pathogen in humans, particularly in 
immunocompromised patients. Candidiasis 
can take many forms, ranging from 
mucosal candidiasis to disseminated 
disease, often with multiple organ 
involvement, depending on the underlying 
host defect.
1-3
 
C. albicans virulence is linked to its 
ability to transition from yeast-form of 
filamentous growth. Several lines of 
evidence support this idea. First, 
histological analyses of tissues infected 
with C. albicans show the presence of 
filaments particularly in the deeper regions 
of the tissue.
4
 Second, using C. albicans 
mutants impaired or altered in their ability 
to filament in mouse models of infections 
showed a correlation between C. albicans 
filamentous growth and host mortality  
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ABSTRACT 
Background and aims: Withania somnifera (W. somnifera), commonly known as 
Ashwagandha, is an important medicinal plant that has been used in Ayurvedic and 
indigenous medicine for over 3,000 years. Candidiasis is one of the most common 
opportunistic fungal diseases in humans. In fact, the most important fungal disease in 
women is vaginal candidiasis. This study aimed to investigate the antifungal effects of 
the extracts of the W. somnifera on Candida albicans (C. albicans). 
Methods: In this experimental research, 9 vaginal samples were collected using the 
sterile swap and Falcon tube by the gynecological specialists. The extracts of the shallot 
and artichoke were prepared using a rotary device. The inhibitory concentration against 
C. albicans was determined using incubation in media. 
Results: The results of this study suggested that the minimum inhibitory concentration 
(MIC) against C. albicans, which is equivalent 50 ppm to 250 ppm has the highest 
concentration of inhibitor. 
Conclusion: The results of this study showed that the antifungal activity of wind cheese 
against C. albicans is good, so it can be used as a drug to treat infections caused by  
C. albicans. 
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from candidiasis.
5-7
 Third, a number of  
C. albicans Eukaryotic cell adhesions and 
virulence-related gene products are more 
abundant in the filamentous form of the 
fungus.
8-10
 
W. somnifera L. Dunal, (Solanaceae), 
commonly known as ashwagandha or 
winter cherry, is a well-known medicinal 
plant in Ayurvedic medicine. The principal 
active compounds include several 
withanolide-type compounds.
11,12
 
“Ashwagandha” is well known for its 
therapeutic use in the ayurvedic system of 
traditional medicine. It has been used as an 
antibacterial, antioxidant, aphrodisiac, liver 
tonic, and anti-inflammatory agent.
13
 
Recently, the antimicrobial activity of  
W. somnifera was studied by several 
authors on control strains (microbial type 
culture collection).
14,15
 It is a reputed health 
food and herbal tonic and used for 
cardiovascular diseases in ethanol 
medicine. It is available for human use 
either as a single herb or an ingredient of 
polyhedral or herb mineral formulations. 
This study aims to investigate the 
antifungal effects of the extracts of the  
W. somnifera on C. albicans. 
 
METHODS 
W. somnifera were collected from the 
Zabol-Iran. After collecting the plants, they 
are rinsed with water and chopped for the 
microbial tests. Then they are dried for 
preparation of the plant extract in the 
shadow. The taxonomical identification of 
the plant was confirmed by Dr. Mirtajadini 
at the Department of Biological Sciences, 
Shahid Bahonar University of Kerman, 
Kerman, Iran. 
For the extract preparation, 10 g dry 
powder of the plant was placed in half-liter 
Erlren Mayer flask containing 100 ml of 
96% ethanol and water. The content of 
flasks was mixed at room temperature for 
24 h with the shaker device with 130 rpm 
speed, and then was filtered using man 
paper No. 2. The solvent was separated 
from the extract by the rotary device and by 
using the vacuum pump (vacuum 
distillation). The obtained extract was 
weighted, and then dissolved in DMSO 
solvent and it was maintained in the 
refrigerator at 4°C to be used. 
After sampling the vaginal using the 
sterile swap and Falcon tube by the 
gynecological specialists, C. albicans 
samples have been from patients 
suspected. Thirty samples were isolated 
and transferred to the laboratory and 
cultivated on agar dextrose Sabouraud and 
broth dextrose saburo according to the 
manufacturer's instructions. After the 
growth of each sample, lam was prepared 
and the candidate samples were identified 
and re-cultivated according to standard 
tables. 
Colonies of C. albicans were prepared 
in the media of Sabouraud dextrose agar at 
37°C in homogenous suspension sterile 
physiology serum, and the rate of the light 
passing of the suspension was measured 
using the spectrophotometry device with 
530 nm. The rate of the light passing of 
90% is necessary for preparing a 
suspension with nearly 106 fungi cells per 
ml. For determining the inhibitory 
concentration of the extracts, incubation in 
the media was used (the concentration of 
50, 100 and 250 ppm was used). Finally, 
they were placed in the incubator and the 
samples were analyzed after 24-48 h. 
 
RESULTS 
The results of this study showed that 
the extract inhibits the growth of  
C. albicans was blowing in soft cheese, so 
that by increasing the inhibitory 
concentration was higher, The results 
showed that the MIC in 50 ppm that a 
fungus strains inhibited while maximum 
inhibitory concentration 250 ppm and  
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two strains of C. albicans in the 
concentration inhibited (Table 1). 
 
Table 1: Minimum inhibitory concentration 
of plant extract against Candida albicans 
minimum inhibitory concentration (ppm) 
Minimum inhibitory 
concentration 
C. albicans 
isolates 
150 1 
100 2 
150 3 
150 4 
250 5 
50 6 
100 7 
150 8 
250 9 
 
DISCUSSION 
The results of this study represent a 
good antifungal effect against C. albicans. 
Pnyrbad extract is such that the higher 
concentration has more inhibitor. The 
inhibitory concentration differences among 
samples of C. albicans were observed  
due to differences in antibiotic-resistant 
infections in them. The results of 
Bokaeian
,
s study showed that the highest 
MIC value of extract was found to be  
250 ppm against Klebsiella pneumoniae  
(K. pneumoniae) and the least MIC values 
for K. pneumoniae was 63 ppm.
16 
Pujavi and Gandhi in their study 
showed that the crude ethanol root extract 
of W. somnifera created strong antibacterial 
activity against two tested pathogens, i.e.  
S. aureus and Salmonella typhi (S. typhi) 
compared to chloroform root extract while 
aqueous root extract showed no inhibitory 
and ethanol extract inhibited the growth of 
S. aureus and S. typhi but did not inhibit  
the growth of Shigella dysenteriae  
(S. dysenteriae). The chloroform extract 
had antibacterial activity against only  
S. aureus. It was observed that none of the 
test bacterial pathogens were inhibited by 
aqueous extract applied. None of the extract 
inhibited the growth of S. dysenteriae.
17
 
Methanolic and aqueous extracts of 
plants W. somnifera and Aloe Vera were tested 
by Srinu for antibacterial activity against 
Pseudomonas aeruginosa (P. aeruginosa), 
Bacillus cereus (B. cereus), Escherichia coli 
(E. coli), S. typhi, Staphylococcus aureus  
(S. aureus) and K. pneumoneae and the result 
show that methanol extracts of plant were 
exhibited potent antibacterial activity when 
compared to the aqueous extracts, which 
are similar to the findings of, who reported 
that the antibacterial activity of aqueous 
extract of W. somnifera on the tested 
pathogen is more effective than the 
methanolic extract. W. somnifera plant 
extract showed more inhibitory activity on 
gram positive organisms (S. aureus and  
B. cereus) when compared to gram negative 
microorganisms, which is in accordance with 
the findings.
18,19
 Phytochemical screening of 
methanolic extract of W. somnifera showed 
various bioactive compounds such as 
tannins’, glycosides, steroids and flavonoids. 
The study by Singariya showed 
chloroform extract of leaves W. somnifera and 
Cenchrus ciliaris had the highest activity, by 
W. somnifera (IZ- 20.38±0.21 mm) and  
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(IZ- 20.67±0.24 mm) by C. ciliaris  
against Bacillus subtilis (B. subtilis) and  
P. aeruginosa, respectively.
20
 
Different parts (root, stem, leaf, flower, 
unripen fruit, ripen fruit and calyx) of  
W. somnifera (RUBL-20668) were 
evaluated by Singariya for their 
antimicrobial (antibacterial and antifungal) 
properties. Maximum extracts were showed 
highest activity against P. aeruginosa and 
B. subtilis. The inhibitory effect is very 
identical in magnitude and comparable with 
that of standard antibiotics. Gentamycin, 
the standard antibacterial drug used was 
effective in inhibiting these bacteria. The 
effect on P. aeruginosa, B. subtilis and  
E. aerogens were comparable to that of 
gentamycin. Ketoconazole, the standard 
antifungal used was effective against the 
fungi (A. flavus).
21
 
In another study, Singh and Kumar 
stated that antimicrobial activity of  
W. somnifera L. Dunal (Solanaceae) has 
been against selected pathogens. Free and 
bound flavonoids of different parts (root, 
stem, leaf and fruit) of W. somnifera have 
been studied for their antimicrobial activity 
using disc diffusion assay against three 
Gram negative bacteria (E. coli MTCC 46, 
Proteus mirabilis (P. mirabilis) MTCC 
3310 and P. aeruginosa MTCC 1934), one 
Gram positive bacteria (S. aureus) MTCC 
3160) and three fungi (C. albicans MTCC 
183, Aspergillus flavus MTCC 277 and 
Aspergillus niger MTCC 282). Total 
activity of bound flavonoid extracts of  
root was found to be same for E. coli,  
P. mirabilis, S. aureus and C. albicans 
(153.84 mg/L). The results of the present 
study reveal that extracts of W. somnifera 
showing great antimicrobial potential 
against test microorganisms may be 
exploited for future antimicrobial drugs.
21
 
Bisht and Rawat in their research 
observed that the methanolic leaf extract of 
W. somnifera was very effective in inhibiting 
the test pathogens, including methicillin 
resistant S. aureus and Enterococcus spp., 
with an average zone of inhibition of  
20.6 mm and 19.4 mm at 2 mg/ml (100 μl) 
concentration, respectively.
22
 
Pandit evaluated the effect of the 
methanol extract of W. somnifera (MEW) 
on the growth and virulence properties of 
Streptococcus mutants and Streptococcus 
sobrinus (S. sobrinus) at sub-minimum 
inhibitory concentration (MIC) levels and 
identified the main components of MEW.  
A GC-MS analysis of the main components 
of MEW was also carried out. MEW 
showed a broad antibacterial range against 
oral bacteria (MIC: 0.125-2 mg/mL). At 
sub-MIC levels, MEW dose-dependently 
increased doubling times of S. mutans and 
S. sobrinus up to 258% and 400%, 
respectively. Furthermore, MEW inhibited 
acid production, acid tolerance, and biofilm 
formation of S. mutans and S. sobrinus at 
sub-MIC levels.
23
 
Kambiz and Aeolians in their project 
performed on the in vitro antimicrobial 
activities of water and methanol extracts 
from two plants on Neisseria gonorrhoea 
(N. gonorrhea) and C. albicans, common 
causes of STIs detected in rural South 
Africa. Extracts from both species together 
with aloin pure from Aloe ferox (A. ferox), 
were evaluated for activity against six strains 
of N. gonorrhoea and nine strains of  
C. albicans. The extracts showed activity 
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against N. gonorrhoea at concentrations of 
ranging from 0.5 (methanol extracts from 
both) to 10 (water extract of W. somnifera 
only) mg/ml, while pure aloin inhibited  
the growth of both microorganisms. Only 
the methanol extract of W. somnifera  
was effective against C. albicans at a 
concentration of 20 mg/ml.
24
 
IG. Mwitaria in a study investigated that 
plant extracts have both bactericidal and 
fungicidal activity. Warbugia ugandensis  
(W. ugandensis) is cytotoxic at IC50<50 µg/ml 
with MIC values of less than 0.78 mg/mL. 
Prunus africana shuts down expression of IL 
7 mRNA at 50 µg/ml. W. somnifera has the 
best antimicrobial (1.5625 mg/ml), immune 
potentiation (2 times IL 7 mRNA expression) 
and safety level (IC50>200 µg/ml). Extractions 
from W. ugandensis and W. somnifera too 
demonstrated with antimicrobial activity.
25
 
Velu and Baskaran in their study 
reported that the ethanol extract of  
W. somnifera showed more activity against 
S. aureus in the zone of diameter 
20.10±0.17 mm and methanol extract of  
W. somnifera showed more activity against 
C. albicans in the zone of diameter 
14.20±0.40 mm compared to other solvent 
extracts. In this study, ethanol extract in 
bacteria and methanol extracts in fungus 
showed a various degree of inhibition to the 
growth of the tested organism than Ethyl 
acetate, chloroform, acetone, Petroleum 
ether, hexane and hot water extract.
26
 
The study of Sundaram revealed that 
higher MIC of W. somnifera was obtained 
for both gram positive bacteria, S. aureus, 
and B. subtilis and for both gram negative 
bacteria E. coli and P. aeruginosa. Ethyl 
acetate extract possesses great inhibitory 
activity for gram positive bacteria,  
S. aureus followed by B. subtilis.
27
 
 
CONCLUSION 
Regarding these results, it is concluded 
that the extract of W. somnifera had a 
strong antifungal effect on tested strains. 
The obtained results suggest that further 
studies for the isolation and identification 
of the more active component of extract are 
required to assess their antifungal activity. 
For this purpose the degree of toxicity of 
these extracts should be determined to 
introduce this plant to the pharmacological 
industry. 
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